Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Business Wire-Archiv vom 24.06.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
24.06.Kinetik Completes Acquisition of Durango Midstream's New Mexico Gathering and Processing System234HOUSTON & MIDLAND, Texas--(BUSINESS WIRE)--Kinetik Holdings Inc. (NYSE: KNTK) ("Kinetik" or the "Company") today completed its previously announced acquisition of Durango Permian LLC ("Durango")...
► Artikel lesen
24.06.Digital Health Acquisition Corp. Announce Closing of Business Combination Transaction with each of VSee Lab and iDoc Virtual Telehealth Solutions164BOCA RATON, Fla.--(BUSINESS WIRE)--Digital Health Acquisition Corp. (Nasdaq: DHAC), a Special Purpose Acquisition Company (SPAC), today announced the closing of its previously announced business combination...
► Artikel lesen
24.06.Wolfspeed Announces Key Milestones and Operational Update454DURHAM, N.C.--(BUSINESS WIRE)--Wolfspeed, Inc. (NYSE: WOLF), the global leader in silicon carbide technology, today provided an update on key milestones and an operational update. Wolfspeed's...
► Artikel lesen
24.06.Merck Provides Update on Phase III TrilynX Study in Locally Advanced Head and Neck Cancer498Not intended for UK-, US- or Canada-based media Merck, a leading science and technology company, today announced the discontinuation of the Phase III randomized TrilynX study evaluating xevinapant...
► Artikel lesen
24.06.Merck KGaA, Darmstadt, Germany, Provides Update on Phase III TrilynX Study in Locally Advanced Head and Neck Cancer386Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the discontinuation of the Phase III randomized TrilynX study evaluating xevinapant plus chemoradiotherapy...
► Artikel lesen
24.06.Verimatrix präsentiert die Plattform zum Schutz mobiler Apps auf den OWASP-Veranstaltungen in Lissabon und San Francisco287Auf den Konferenzen werden Live-Demos von Verimatrix XTD, der Schutz mobiler Apps, die Überwachung von Cybersecurity-Bedrohungen und die Reaktionsmöglichkeiten auf Vorfälle vorgestellt Verimatrix...
► Artikel lesen
24.06.Grid Dynamics Holdings, Inc.: Grid Dynamics startet GenAI- Toolkit zur Optimierung der Produktivität von Entwicklern311Wichtigste Punkte: Grid Dynamics führt ein Set von Tools für die End-to-End-Automatisierung von mehreren üblichen Softwareentwicklungsszenarien ein. Dank dieser leistungsstarken, zweckgebundenen...
► Artikel lesen
24.06.CheckedUp Honored With the Red Dot Product Design Award in Medical Devices and Technology for 2024538CheckedUp today announced the Exam Room Digital Consult product received the prestigious Red Dot Award in 2024 Product Design Winner in Medical Devices and Technology. The Red Dot Award is an annual...
► Artikel lesen
24.06.SONOVEIN FDA Pivotal Study Treatments Completed: Theraclion Reaches Key Milestone on Schedule493Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE) innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy...
► Artikel lesen
24.06.Veolia Environnement: Information Relating to the Total Number of Voting Rights Forming the Share Capital590Article L. 238-8-II of the French commercial Code and article 223-16 of the AMF (French Financial Markets Authority) general regulation Regulatory News: Corporate name of the issuer:...
► Artikel lesen
24.06.Fideres's Research Uncovers Potential Anticompetitive Effects in the Grand Piano Market279Economic consultancy finds that Steinway, a leading manufacturer of pianos, has elaborated a scheme to monopolize the market for grand pianos worldwide. A recent investigation by Fideres, an economic...
► Artikel lesen
24.06.Aelis Farma: Availability of the Description of the Share Buyback Program237Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 Ticker: AELIS) (Paris:AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, announces...
► Artikel lesen
24.06.TotalEnergies SE: Disclosure of Transactions in Own Shares349Regulatory News: In accordance with the authorizations given by the shareholders' general meeting on May 24,2024, to trade on its shares and pursuant to applicable law on share repurchase, TotalEnergies...
► Artikel lesen
24.06.MaaT Pharma Appoints Gianfranco Pittari, M.D. Ph.D, as Chief Medical Officer280Regulatory News: MaaT Pharma (EURONEXT: MAAT the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing...
► Artikel lesen
24.06.Eurofins: Purchases of Own Shares From the 17th June to the 21th of June 2024423Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total...
► Artikel lesen
24.06.Decarbonization: Air Liquide Selected to Invest up to 850 MUSD in Largest Low-carbon Oxygen Production in the Americas379Regulatory News: Air Liquide (Paris:AI) plans to invest up to 850 million dollars to build, own and operate four Large Modular Air separation units as well as related infrastructure in the framework...
► Artikel lesen
24.06.Verimatrix To Showcase Mobile App Protection Platform at OWASP Events in Lisbon and San Francisco230Conferences to showcase Verimatrix XTD live demos; mobile app protection, cybersecurity threat monitoring, and incident response capabilities Regulatory News: Verimatrix, (Euronext Paris:...
► Artikel lesen
24.06.Airway Therapeutics, Inc.: Airway Therapeutics gewinnt den ATS Whitsett Award 2024 für die Zusammenfassung der positiven Phase-1b-Ergebnisse von Zelpultide Alfa bei Frühgeborenen mit dem Risiko einer bronchopulmonalen Dysplasie219Das Unternehmen plant den Beginn einer multinationalen Zulassungsstudie mit Zelpultid alfa (rhSP-D) in Q4/2024 in Europa. An der Studie werden mehr als 300 Neugeborene teilnehmen, die nach 23 Wochen...
► Artikel lesen
24.06.Latch, Inc. to Acquire HelloTech, Officially Launching DOOR Services299ST. LOUIS--(BUSINESS WIRE)--Latch, Inc., soon to be DOOR, today announced it has agreed to acquire HelloTech, Inc., a service platform delivering on-demand, last-mile installation, setup, and connected...
► Artikel lesen
24.06.América Móvil to Acquire a Controlling Interest in ClaroVTR391MEXICO CITY, Mexico and DENVER, USA--(BUSINESS WIRE)--América Móvil S.A.B. de C.V. ("América Móvil" or "AMX") (BMV: AMX, NYSE: AMX and AMOV) and Liberty Latin America Ltd. ("Liberty Latin America"...
► Artikel lesen
Seite:  Weiter >>